Jack E. Henningfield
|This article is a stub. You can help by expanding it.|
Jack E. Henningfield, Ph.D. is a pharmacologist at Johns Hopkins University, and is an Anti-Tobacco Expert.
Jack Edward Henningfield Ph.D. was the Chief of Pharmacology at the Clinical Pharmacology Branch at the National Institutes of Health, National Institute on Drug Abuse, Addiction Research Center, Baltimore, MD (Orleans & Slade). He was the Chief of Pharmacology research at NIH/NIDA/ARC (New York Times, 4/29/94). He was recommended by Matthew Bars as expert to give a talk on nicotine addiction. Henningfield termed a 1983 Philip Morris/Victor J. DeNoble rat study "a strong study." He says the study showed that rats quickly became addicted to nicotine. He says the study didn't show withdrawal symptoms because scientists a decade ago did not know enough to recognize a rat's withdrawal symptoms.(Associated Press 4/1/94) He was a contributor to Orleans & Slade Nicotine Addiction Principles and Management in 1993. The tests of tar nicotine levels are performed by tobacco company laboratories under FTC supervision, but scientific studies over recent years have shown that smokers get the same amount of tar and nicotine no matter what cigarette they smoke. According to the NY Times, "A smoker can draw 3 milligrams of nicotine out of a cigarette that is rated as a 1 milligram yield by the FTC test," per Dr. Jack Henningfield (AP 5/2/94). Dr. Henningfield did research confirming Victor DeNoble's nicotine analogue/nicotine addiction studies.(V. DeNoble 5/26/94) Dr. Henningfield testified before the U.S. Food and Drug Administration Drug Abuse Advisory Committee on 8/2/94. Henningfield says that smokers who consume 10 to 20 milligrams of nicotine a day would produce dependence and withdrawal symptoms, but at 5 milligrams a day such symptoms might not occur. (DJ 8/2/94)
Dr. Henningfield resides in Baltimore, MD and was employed by Pinney Associates as Vice President for Research and Health Policy. He is also an Associate Professor at John's Hopkins University School of Medicine, Dept. of Psychiatry. He was with the National Institute on Drug Abuse (NIDA) for 16 years. He was brought on to NIDA in 1980 to help develop a nicotine research program. NIDA is part of the National Institutes of Health. He left NIDA in September of 1996. In 1986, the Surgeon General asked the National Cancer Institute to develop a report on smokeless tobacco. Dr. Henningfield was NIDA's lead scientist to contribute to that report. (Jack E. Henningfield's sworn statement 12/26/96, State of Florida, et al., vs. ATC, et al.) Dr. Henningfield can be located at 5504 Roland Avenue, Baltimore, MD 21210. He has a Ph.D. in experimental psychology in psycho-pharmacology. (State of Florida's Proposed Plaintiff's Disclosure of Expert Witnesses, 2/5/97)
<tdo>resource_id=4441 resource_code=henningfield_jack_e search_term=Jack E. Henningfield</tdo>